27 results
8-K
EX-99.4
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit
DEFM14A
ELYM
Eliem Therapeutics Inc
4 Jun 24
Proxy related to merger
8:00am
between Mr. Thomas and members of the Special Committee and Eliem’s nominating and corporate governance committee.
On March 24, 2024, representatives … to serve.
Andrew Levin, M.D., Ph.D. and Liam Ratcliffe, M.D., Ph.D. were recommended for election by the nominating and corporate governance committee
PREM14A
ELYM
Eliem Therapeutics Inc
17 May 24
Preliminary proxy related to merger
4:36pm
meetings between Mr. Thomas and members of the Special Committee and Eliem’s nominating and corporate governance committee.
On March 24, 2024 … will be unable to serve.
Andrew Levin, M.D., Ph.D. and Liam Ratcliffe, M.D., Ph.D. were recommended for election by the nominating and corporate governance
DEFA14A
ELYM
Eliem Therapeutics Inc
11 Apr 24
Additional proxy soliciting materials
8:10am
agreements, voting agreements and similar documents, instruments or agreements relating to the organization or governance of such Person, in each
8-K
EX-2.1
1xmyr8ohgf
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
DEF 14A
cabl4
8 Apr 22
Definitive proxy
4:20pm
10-K
w4xshtgl1nu0l
7 Mar 22
Annual report
4:03pm
10-Q
tjisbc1savn2r
13 Sep 21
Quarterly report
4:01pm
424B4
r3u3q0nq2usdksuo0
11 Aug 21
Prospectus supplement with pricing info
5:05pm